Julien Potet from MSF describes the underlying causes limiting access to antisera in low- and middle-income countries. What do snakebites, tetanus and rabies…
-
General How Access to Life-Saving Antisera is Dwindling Fast, and What to do About it
-
MSF To Err is Humanitarian
Leslie Shanks describes the challenging task of implementing error reporting within Médecins sans Frontières’ programmes. I remember that day as if it…
-
Conference news MSF Scientific Day 2013
Does blogging help patients cope with the lengthy and toxic treatment for multidrug resistant tuberculosis? Do humanitarian responses to crises fail to…
-
General Seasonal Malaria Chemoprevention: Good News in a Year Marked by Malaria Emergencies
Estrella Lasry from Médecins Sans Frontières reflects on the roll out of seasonal malaria chemoprevention in Mali and Chad. In 2012, MSF…
-
MSF Vaccines in Developing Countries: Why the High Prices?
Kate Elder and Jennifer Cohn from Médecins Sans Frontières question why new vaccines are so expensive. Global health leaders will gather in…
-
MSF Familiar Enemies in Conflict and TB
Charles Ssonko from Médecins Sans Frontières reflects on the challenges of treating TB in unstable settings. Amid the justified excitement surrounding the…
-
General Buruli Ulcer in a Brave New World
Daniel O’Brien from Médecins Sans Frontières/Doctors Without Borders describes his recent visit to Cameroon and calls for research and action to tackle…
-
General The Horseman, the Donkey and the Virus: Hepatitis E in South Sudan
Médecins Sans Frontières’ Ian Woolley reports on the current hepatitis E outbreak in the refugee camps of South Sudan. Pestilence, along with…
-
Access Stuck in a time warp: WHO-brokered global R&D action plan shelved
Julien Potet and Katy Athersuch from Médecins Sans Frontières’ Access Campaign discuss a backward step for medical research & development. Ten years…
-
General Children with TB – Global Interest at Last
At last, tackling tuberculosis (TB) in children is on the international agenda. This year, for the first time, an estimate of the…
-
General Gathering the Evidence to Improve Health Care in Developing Countries: Meta-analysis without Borders
Nathan Ford and Philipp du Cros from Médecins Sans Frontières ask whether it is time for ‘Meta-analysers without Borders’ A couple of…
-
General India’s patent law on trial
This month, two critical legal battles between multinational pharmaceutical companies and the Indian government are taking center stage in an ongoing struggle…